Literature DB >> 2722846

Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations.

P W Gray1, G Flaggs, S R Leong, R J Gumina, J Weiss, C E Ooi, P Elsbach.   

Abstract

The bactericidal permeability increasing protein (BPI) is a 50-60-kDa membrane-associated protein isolated from granules of polymorphonuclear leukocytes. A full-length cDNA clone encoding human BPI has been isolated and the derived amino acid sequence reveals a structure that is consistent with previously determined biological properties. BPI may be organized into two domains: the amino-terminal half, previously shown to contain all known antimicrobial activity, contains a large fraction of basic and hydrophilic residues. In contrast, the carboxyl-terminal half contains more acidic than basic residues and includes several potential transmembrane regions which may anchor the holoprotein in the granule membrane. The cytotoxic action of BPI is limited to many species of Gram-negative bacteria; this specificity may be explained by a strong affinity of the very basic aminoterminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial envelope. The amino-terminal end of BPI exhibits significant similarity with the sequence of a rabbit lipopolysaccharide-binding protein, suggesting that both molecules share a similar structure for binding lipopolysaccharides.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722846

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Autoantibodies to molecular targets in neutrophils in patients with ulcerative colitis.

Authors:  J Brimnes; O H Nielsen; A Wiik; N H Heegaard
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

Review 2.  A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein.

Authors:  O Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 3.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

Review 4.  Antibiotic proteins of human neutrophils.

Authors:  J K Spitznagel
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.

Authors:  Marcia L Moss; Gary Powell; Miles A Miller; Lori Edwards; Bin Qi; Qing-Xiang Amy Sang; Bart De Strooper; Ina Tesseur; Stefan F Lichtenthaler; Mara Taverna; Julia Li Zhong; Colin Dingwall; Taheera Ferdous; Uwe Schlomann; Pei Zhou; Linda G Griffith; Douglas A Lauffenburger; Robert Petrovich; Jörg W Bartsch
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

6.  Fluoxetine-resistance genes in Caenorhabditis elegans function in the intestine and may act in drug transport.

Authors:  Robert K M Choy; John M Kemner; James H Thomas
Journal:  Genetics       Date:  2005-08-22       Impact factor: 4.562

7.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

8.  Synthesis and secretion of wild-type and mutant human plasma cholesteryl ester transfer protein in baculovirus-transfected insect cells: the carboxyl-terminal region is required for both lipoprotein binding and catalysis of transfer.

Authors:  J Au-Young; C J Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

9.  Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein.

Authors:  F R Kohn; A H Kung
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

Review 10.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.